SPIOLTO® RESPIMAT®
Overview
Product overview
SPIOLTO® RESPIMAT® is indicated as a maintenance bronchodilator treatment in adult patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Product Key Facts
Indications
Chronic obstructive pulmonary disease (COPD).
Active ingredient
Tiotropium/olodaterol.
Legal category
Prescription only medicine.
Concentration
Tiotropium 2.5 micrograms/olodaterol 2.5 micrograms per puff.
Administration form
Oral inhalation via RESPIMAT® inhaler.
Dosage form
Inhalation solution.
Pack sizes
Single pack: One RESPIMAT®
reusable inhaler and one 4-mL
cartridge.
Reference:
-
SPIOLTO® RESPIMAT® Solution for Inhalation, approved package insert. R1g/UK/SPC/a 16/06/2015. Approved 10/2020.
